Pasithea Therapeutics Corp. Quarterly Interest Expense in USD from Q1 2023 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Pasithea Therapeutics Corp. quarterly/annual Interest Expense history and growth rate from Q1 2023 to Q2 2023.
  • Pasithea Therapeutics Corp. Interest Expense for the quarter ending June 30, 2023 was -$117K.
  • Pasithea Therapeutics Corp. annual Interest Expense for 2022 was $102.000, a 79.9% decline from 2021.
Interest Expense, Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 -$117K Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $6.39K Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.